Drug Shortage Report for PEGLYTE POWDER
| Report ID | 149215 |
| Drug Identification Number | 00777838 |
| Brand name | PEGLYTE POWDER |
| Common or Proper name | PEGLYTE POWDER |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM BICARBONATE SODIUM SULFATE MACROGOL |
| Strength(s) | 3.05G 5.85G 6.76G 22.96G 238.18G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | 4X70G |
| ATC code | A06AD |
| ATC description | DRUGS FOR CONSTIPATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-11-09 |
| Estimated end date | 2021-12-10 |
| Actual end date | 2021-11-24 |
| Shortage status | Resolved |
| Updated date | 2021-11-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-11-25 | English | Compare |
| v4 | 2021-11-24 | French | Compare |
| v3 | 2021-11-24 | English | Compare |
| v2 | 2021-11-15 | French | Compare |
| v1 | 2021-11-15 | English | Compare |
Showing 1 to 5 of 5